News

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...
Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients market is poised for significant growth, expanding biopharmaceutical pr ...
US pharma major AbbVie yesterday announced a $195 million investment in its North Chicago, Illinois manufacturing plant to ...
As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...
The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.
AbbVie has announced a USD 195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic ...
An empty reserve undermines national preparedness for health crises like pandemics and bioterrorism where rapid access to ...
In Asia, firms such as Aurobindo Pharma, Sun Pharmaceutical Industries, and Zhejiang Hisun Pharmaceutical have established themselves as key players in the antibiotics active pharmaceutical ingredient ...
The Active Pharmaceutical Ingredients (APIs) market is expected to reach US$ 403.64 billion by 2033 from US$ 226.12 billion in 2024, with a CAGR of 6.65% from 2025 to 2033. The rising incidence of ...
RUSAN PHARMA PRIVATE LIMITED announced that the USFDA has granted GMP approval for its API facility in Ankleshwar (Gujarat, India).
The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% from 2025 to 2030, according to a new ...
Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all.